Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Kanae Togo"'
Autor:
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 485-497 (2024)
Background The Japanese National Immunization Program currently includes the pediatric 13 valent pneumococcal conjugate vaccine (PCV13) to prevent pneumococcal infections. We aimed to evaluate the cost-effectiveness of 20-valent PCV (PCV20) as a pedi
Externí odkaz:
https://doaj.org/article/71b05513c01b4d099126da3986cf1959
Autor:
Masato Bingo, Katsuyuki Fukutake, Kanae Togo, Linghua Xu, José Maria Jimenez Alvir, Ian Winburn, Toshiyuki Karumori
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 541-552 (2024)
Abstract Background Treatment for haemophilia A has expanded from plasma-derived factor VIII (pdFVIII) and standard half-life (SHL) recombinant FVIII (rFVIII) to extended half-life (EHL) rFVIII and non-factor products that mimic FVIII activity. Objec
Externí odkaz:
https://doaj.org/article/6ef9edd9782e4bc589028952cd106adb
Autor:
Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W. Law, Kazumasa Kamei
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1665-1682 (2024)
Abstract Introduction Respiratory syncytial virus (RSV) is one of the major causes of respiratory tract infections among children. Until recently, the monoclonal antibody palivizumab was the only RSV prophylaxis available in Japan. In 2024, the bival
Externí odkaz:
https://doaj.org/article/e4484d8b1a2844a6a518eae7db045f8b
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Clinical characteristics and treatment practice of patients with migraine in Japan in real-world setting have not been fully investigated. We conducted a retrospective cohort study using claims database to understand the clinical
Externí odkaz:
https://doaj.org/article/89da59081f1c4026bda12b1e8cd48324
Publikováno v:
Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology, Vol 35, Iss , Pp 1-8 (2024)
Background: Patterns of analgesic use before and after total joint replacement (TJR) in patients with knee/hip osteoarthritis (OA) is not well reported. Methods: This retrospective longitudinal analysis used JMDC claims data of patients who underwent
Externí odkaz:
https://doaj.org/article/fd68c8d4bc2c422b9af24eba328abc12
Publikováno v:
Breast, Vol 70, Iss , Pp 1-7 (2023)
Purpose: The optimal treatment following endocrine therapy (ET) plus a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) has not been established. We aimed to investigate treatment patterns and time to treatment failure (TTF) of subsequent therapy afte
Externí odkaz:
https://doaj.org/article/1e0f5ed4fb38406e9e37439d595dbcab
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 88-99 (2023)
Background/Aims Patients with ulcerative colitis (UC) are at an increased risk of certain infections and malignancies compared with the general population. Incidence rates (IRs) of hospitalized infections, herpes zoster (HZ), and malignancies in pati
Externí odkaz:
https://doaj.org/article/7f22d74d08d545b4810393c231d069dd
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 2, Pp 297-316 (2019)
Abstract Introduction Transthyretin amyloid cardiomyopathy (ATTR-CM)—a debilitating, fatal disease resulting from the deposition of transthyretin (TTR) amyloid fibrils—can be hereditary due to mutations in the TTR gene (ATTRm) or wild type (ATTRw
Externí odkaz:
https://doaj.org/article/585df41f1f9248ec814a3ed30c351e63
Autor:
Yasushi Yatabe, MD, PhD, Yasumasa Yoshiki, MPH, Koichi Matsumura, PhD, Kanae Togo, MSc, Hironori Kikkawa, PhD, Laura Iadeluca, PhD, MPH, Benjamin Li, PhD, Kazuto Nishio, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100136- (2021)
Introduction: Diagnostic testing is important in determining appropriate treatment for individuals with lung cancer. In 2018, testing of five biomarkers (EGFR, ALK, ROS1, BRAF, programmed cell death-ligand 1 [PD-L1]) was approved in Japan. Informatio
Externí odkaz:
https://doaj.org/article/32ccbf8e9d9347f381ea1ab2194febed
Autor:
Kenji Araki, Nobuhiro Matsumoto, Kanae Togo, Naohiro Yonemoto, Emiko Ohki, Linghua Xu, Yoshiyuki Hasegawa, Hirofumi Inoue, Sakiko Yamashita, Taiga Miyazaki
Publikováno v:
Health and Technology. 13:253-262
Purpose We generated methods for evaluating clinical outcomes including treatment response in oncology using the unstructured data from electronic health records (EHR) in Japanese language. Methods This retrospective analysis used medical record data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085df9b24e534c44a6a51f0224f382c4
https://doi.org/10.1007/s12553-023-00739-1
https://doi.org/10.1007/s12553-023-00739-1